Medicxi

📍 London, GB
🏷️ vc
Visit Website ↗
Investment Thesis

Medicxi invests in high-potential life sciences companies developing transformative therapies and vaccines, with a focus on addressing unmet medical needs in rare diseases, autoimmune disorders, and infectious diseases.

Stage Focus
Series B, Series C, and acquisitions (pre-IPO)

Preferred startup development maturity for initial funding deployment.

Sectors & Themes

Life sciences, biotech, and pharmaceutical innovations, including next-generation vaccines, antibody therapies, and rare disease treatments

Core thematic spaces, technologies, and target market segments of interest.

Check Size Range
N/A

Standard financial allocation per investment round.

Outreach & Dossier Intelligence

Direct Verification Contact Email Pattern

[email protected] | [email protected]

Thesis Dossier Analysis Scorecard

Our agent analyzer scanned portfolio holdings and verified absolute match parameters...

Unlock Verified Partner Contacts

Find verified email templates, direct outreach copy created by AI, and calculate exact thesis match scores with 1-click.

Create Free Account to Unlock

Takes less than 30 seconds · No card required

Investment Team (36)